Model-informed Individualized Treatment of Anti-infective Drugs

Launched by SHANDONG UNIVERSITY · Nov 29, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how to improve the treatment of infections in the bones and joints, known as osteoarticular infections. The researchers want to personalize the use of anti-infective drugs by looking closely at how these medications work in the blood and tissues of patients. By doing this, they hope to find the best treatment plan for each individual.

To be eligible for this trial, participants should have a suspected or confirmed osteoarticular infection and be receiving treatment with anti-infective drugs. Unfortunately, pregnant or breastfeeding women cannot take part, and there are other specific factors that might make someone ineligible. If you decide to participate, you can expect to have your drug levels monitored to help tailor your treatment more effectively. This study is currently looking for volunteers, so if you fit the criteria and are interested, please consider joining.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with suspected/confirmed osteoarticular infections who are undergoing anti-infective drug therapy.
• Exclusion Criteria:
• • Pregnant/lactating women.
• • There are other factors that the researchers think are not suitable for inclusion.